Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor

Archives of Biochemistry and Biophysics

Volumn 351, Issue 1, 1998, Pages 17-26

  Opalenik, Susan R ^a   Ding, Qiang ^a   Mallery, Susan R ^c   Thompson, John A ^a,b,d  

^a UAB Department of Surgery   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

FGF 1; Glutathione; HIV 1 TAT; Oxidative stress

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ACIDIC FIBROBLAST GROWTH FACTOR; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BUTHIONINE SULFOXIMINE; CYSTEINE; CYTIDINE TRIPHOSPHATE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE ESTER; GUANOSINE TRIPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SERINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPLETION; FIBROBLAST; HIGH ENERGY PHOSPHATE; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0032029781     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1997.0566     Document Type: Article

References (75)

1. Akerboom T. P., Sies H. Transport of glutathione, glutathione disulfide, and glutathione conjugates across the hepatocyte plasma membrane. Methods Enzymol. 173:1989;523-534.
2. Anderson M. E., Meister A. Glutathione Monoesters. Anal. Biochem. 183:1989;16-20.
3. Aukrust P., Svadal A. M., Muller F. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood. 86:1995;258-267.
4. Bailer R. T., Lazo A., NG-Bautista C. L. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related kaposi's sarcoma cell strains and in sera from HIV+/KS- patients. J. Interferon. Cytol. Res. 15:1995;473-483.
5. Barbanti-Brodano G., Sampaolesi R., Campioni D. HIV-1 tat acts as a growth factor and induces angiogenic activity in BK virus/tat transgenic mice. Antibiot. Chemother. 46:1994;88-101.
6. Baruchel S., Wainberg M. A. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J. Leukocyte Biol. 52:1992;111-114.
7. Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:1989;575-606.
8. Bussolino F., Arese M., Montrucchio G. Platelet activating factor producedin vitro. J. Clin. Invest. 96:1995;940-952.
9. Cupp C., Taylor J. P., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 8:1993;2231-2236.
10. Curran J. W., Morgan W. M., Hardy A. M., Jaffe H. W., Darrow W. W., Dowdle W. R. The epidemiology of AIDS: current status and future prospects. Science. 229:1985;1352-1357.
11. Dayton A. L., Sodroski J. G., Rosen C. A., Goh W. C., Haseltine W. A. The trans-activator gene of the human T-cell lymphotropic virus type II is required for replication. Cell. 44:1986;941-947.
12. de Quay B., Malinverni R., Lauterburg B. H. Glutathione depletion in HIV-infected patients: Role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS. 6:1992;815-819.
13. Delli Bovi P., Donti E., Knowles D. M. Presence of chromasomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res. 46:1986;6333-6338.
14. Droge W. Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetyl-cysteine. Pharmacology. 46:1993;61-65.
15. Engleka K., Maciag T. Inactivation of human fibroblast growth factor-1 activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalzed oxidation. J. Biol. Chem. 267:1992;11307-11315.
16. Ensoli B., Barillari G., Buonaguro L., Gallo R. C. Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma. Adv. Exp. Med. Biol. 303:1991;27-38.
17. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345:1990;84-86.
18. Ensoli B., Buonaguro L., Barillari G. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
19. Ensoli B., Nakamura S., Salahuddin S. Z. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science. 243:1989;223-226.
20. Fisher A. G., Feinberg M. B., Josephs S. F. The trans-activator gene of HTLV-III is essential for virus replication. Nature. 320:1986;367-371.
21. Flores S. C., Marecki J. C., Harper K. P., Bose S. K., Nelson S. K., McCord J. M. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA. 90:1993;7632-7636.
22. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
23. Forough R., Engleka K., Thompson J. A., Jackson A., Imamura T., Maciag T. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1, potential role of RNA secondary structure. Biochim. Biophys. Acta. 1090:1991;293-298.
24. Friedman-Kien A. E. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J. Am. Acad. Dermatol. 5:1981;468-471.
25. Geisbuhler T., Altschuld R. A., Trewyn R. W., Ansel A. J., Lanka K., Brierley G. P. Adenine nucleotide metabolism and compartmentalization in isolated adult rat heart cells. Circ. Res. 54:1984;536-546.
26. Gottlieb G. J., Ackerman A. B. Kaposi's sarcoma: An extensively disseminated form in young homosexual men. Hum. Pathol. 13:1982;882-892.
27. Herzenberg L. A., DeRosa S. C., Dubs J. G. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA. 94:1997;1967-1972.
28. Jackson A., Friedman S., Zhan X., Engleka K. A., Forough R., Maciag T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 89:1992;10691-10695.
29. Jackson A., Tarantini F., Gamble S., Friedman S., Maciag T. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem. 270:1995;33-36.
30. Jerome V., Leger J., Devin J., Baulieu E. E., Catelli M. G. Growth factors acting via tyrosine kinase receptors induce HSP90alpha gene expression. Growth Factors. 4:1991;317-327.
31. Jornot L., Mirault M. E., Junot A. F. Differential expression of hsp70 stress proteins in human endothelial cells exposed to heat shock and hydrogen peroxide. Am. J. Respir. Cell Mol. Biol. 5:1991;265-275.
32. Lotz M., Clark-Lewis I., Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 124:1994;365-371.
33. Mallery S. R., Bailer R. T., Hohl C. M. Cultured AIDS-related kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: Implication for oxidant stress in AIDS-KS pathogenesis. J. Cell. Biochem. 59:1995;317-328.
34. Mallery S. R., Lantry L. E., Laufman H. B., Stephens R. E., Brierley G. P. Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. J. Cell. Biochem. 53:1993;360-372.
35. Mallery S. R., Laufman H. B., Solt C. W., Stephens R. E. Association of cellular thiol redox status with mitogen-induced calcium mobilization and cell cycle progression in human fibroblasts. J. Cell. Biochem. 45:1991;82-92.
36. Mallery S. R., NG-Bautista C. L., Lantry L. E. Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities. J. Cell. Biochem. 56:1994;568-581.
37. Mann D. A., Frankel A. D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO. J. 10:1991;1733-1739.
38. McCord J. M. Molecular Basis of Oxidative Damage by Leukocytes. 1992;CRC Press, Boca Raton. p. 225-239.
39. McNutt N. S., Fletcher V., Conant M. A. Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am. J. Pathol. 111:1983;62-77.
40. Milani D., Zauli G., Neri L. M., Marchisio M., Previati M., Capitani S. Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol. 74:1993;2587-2594.
41. Nabell L. M., Raja R. H., Sayeski P. P., Paterson A. J., Kudlow J. E. Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner. Cell Growth Differ. 5:1994;87-93.
42. Naidu Y. M., Rosen E. M., Zitnick R. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc. Natl. Acad. Sci. USA. 91:1994;5281-5285.
43. Opalenik S. R., Shin J. T., Wehby J. N., Mahesh V. K., Thompson J. A. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J. Biol. Chem. 270:1995;17457-17468.
44. Panus P. C., Wright S. A., Chumley P. H., Radi R., Freeman B. A. The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-mediated cell injury. Arch. Biochem. Biophys. 294:1992;695-702.
45. Pitot, H. C. 1986, in, Fundamentals of Oncology, 323, 346, Marcel Dekker, New York.
46. Pocsik E., Higuchi M., Aggarwal B. B. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res. 11:1992;317-325.
47. Puri R. K., Aggarwal B. B. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:1992;3787-3790.
48. Purvis S. F., Georges D. L., Williams T. M., Lederman M. M. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell. Immunol. 1992;144-142.
49. Raju P. A., Herzenberg L. A., Roederer M. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compated in in vitro studies of HIV replication. AIDS Res. Human Retroviruses. 10:1994;961-967.
50. Robinson M. K., Hong R. W., Wilmore D. W. Glutathione deficiency and HIV infection. Lancet. 339:1992;1603-1604.
51. Roederer M., Ela S. W., Staal F. J., Herzenberg L. A. N-acetylcysteine: A new approach to anti-HIV therapy. AIDS Res. Hum. Retroviruses. 8:1992;209-217.
52. Roederer M., Staal F. J., Ela S. W., Herzenberg L. A. N-acetylcysteine: Potential for AIDS therapy. Pharmacology. 46:1993;121-129.
53. Safai B., Johnson K. G., Myskowski P. L. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:1985;744-750.
54. Salahuddin S. Z., Nakamura S., Biberfeld P. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science. 242:1988;430-433.
55. Sano H., Forough R., Maier J. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J. Cell Biol. 110:1990;1417-1426.
56. Scala G., Ruocco M. R., Ambrosino C. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179:1994;961-971.
57. Shin J. T., Opalenik S. R., Wehby J. N. Serum-starvation induces the extracellular appearance of FGF-1. 1995. Biochim. Biophys. Acta. 1312:1996;27-38.
58. Sodroski J., Patarca R., Rosen C., Wong S. F., Haseltine W. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science. 229:1985;74-77.
59. Sodroski J., Rosen C., Wong-Staal F. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science. 227:1985;171-173.
60. Sorger P. K., Pelham H. R. B. Cloning and expression of a gene encoding hsc73, the major hsp70-like protein in unstressed rat cells. EMBO J. 6:1987;993-998.
61. Staal F. J., Ela S. W., Roederer M., Anderson M. T., Herzenberg L. A. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 339:1992;909-912.
62. Staal F. J., Roederer M., Herzenberg L. A. Glutathione and immunophenotypes of T and B lymphocytes in HIV-infected individuals. Ann. N.Y. Acad. Sci. 651:1992;453-463.
63. Staal F. J. TF. J., Ela S. W., Roederer M., Anderson M. T., Herzenberg L. A. Lancet. 339:1992;909-912.
64. Tarantini F., Gamblel S., Jackson A., Maciag T. The cysteine residue responsible for the release of fibroblast growth factor-1 resides in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem. 270:1995;29039-29042.
65. Taylor J. P., Cupp C., Diaz A. Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc. Natl. Acad. Sci. USA. 89:1992;9617-9621.
66. Thompson J. A., Anderson K. D., DiPietro J. M. Site-directed neovessel formation in vivo. Science. 241:1988;1349-1352.
67. Thompson J. A., Haudenschild C. C., Anderson K. D., DiPietro J. M., Anderson W. F., Maciag T. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;7928-7932.
68. Vogel J., Hinrichs S. H., Reynolds R. K., Luciw P. A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 335:1988;606-611.
69. Walter M. A., Jurouglu R., Caulfield J., Vasconez L. O., Thompson J. A. Enhanced peripheral nerve regeneration by fibroblast growth factor (FGF-1). Lymphokine Cytokine Res. 12:1993;135-141.
70. Weindel K., Marme D., Weich H. A. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 183:1992;1167-1174.
71. Westendorp M. O., Li-Weber M., Frank R. W., Krammer P. H. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:1994;4177-4185.
72. Westendorp, M. O. Shatrov, V. A. Schulze-Osthoff, K. et al., HIV-1 tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state, EMBO. J. 14, 546, 554.
73. Wu B. J., Morimoto R. I. Transcription of the human hsp70 gene is induced by serum stimulation. Proc. Natl. Acad. Sci. USA. 82:1985;6070-6074.
74. Zauli G., Davis B. R., Re M. C., Visani G., Furlini G., La Placa M. Tat protein production of transforming growth factor-beta by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood. 80:1992;3036-3043.
75. Zauli G., Furlini G., Re M. C., Milani D., Capitani S., La Placa M. Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes. Microbiologica. 16:1993;115-120.